MQ02-439, also known as 1-methoxynoraporphine, is a serotonin 5-HT2C receptor agonist of the noraporphine family. It is a potent and selective full agonist of the serotonin 5-HT2C receptor, with an EC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) of 103 nM (96%). The drug showed no activation of the serotonin 5-HT2A and 5-HT2C receptors at concentrations of up to 10,000 nM. However, it did show weak antagonism of these two receptors. The chemical synthesis of MQ02-439 has been described. Various analogues of MQ02-439 have also been described, including some with potent serotonin 5-HT2A receptor agonist activity. The (S)- enantiomer of MQ02-439 is known as MQ02-592 and is the more potent enantiomer in terms of serotonin 5-HT2C receptor agonism. MQ02-439 was described in the scientific literature by Qi Mao and colleagues in 2020.
See also Noraporphine 11-Chloroasimilobine 2-Hydroxy-11-(2-methylallyl)oxynoraporphine Nornuciferine Asimilobine 11-Methoxyasimilobine
References


